These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26126434)

  • 21. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells.
    Appuhamy JA; Nayananjalie WA; England EM; Gerrard DE; Akers RM; Hanigan MD
    J Dairy Sci; 2014; 97(1):419-29. PubMed ID: 24183687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of feed deprivation on the AMPK signaling pathway in skeletal muscle of broiler chickens.
    Hu X; Liu L; Song Z; Sheikhahmadi A; Wang Y; Buyse J
    Comp Biochem Physiol B Biochem Mol Biol; 2016 Jan; 191():146-54. PubMed ID: 26497445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acids regulate energy utilization through mammalian target of rapamycin complex 1 and adenosine monophosphate activated protein kinase pathway in porcine enterocytes.
    Xiao H; Zha C; Shao F; Wang L; Tan B
    Anim Nutr; 2020 Mar; 6(1):98-106. PubMed ID: 32211535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes.
    Tong X; Smith KA; Pelling JC
    Mol Carcinog; 2012 Mar; 51(3):268-79. PubMed ID: 21538580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways.
    Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H
    Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
    Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X
    Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined cancer therapy with non-conventional drugs: all roads lead to AMPK.
    Chen S; Zhu X; Lai X; Xiao T; Wen A; Zhang J
    Mini Rev Med Chem; 2014; 14(8):642-54. PubMed ID: 25138094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMPK, the metabolic syndrome and cancer.
    Luo Z; Saha AK; Xiang X; Ruderman NB
    Trends Pharmacol Sci; 2005 Feb; 26(2):69-76. PubMed ID: 15681023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases].
    Foretz M; Taleux N; Guigas B; Horman S; Beauloye C; Andreelli F; Bertrand L; Viollet B
    Med Sci (Paris); 2006 Apr; 22(4):381-8. PubMed ID: 16597407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of AMP-activated protein kinase in mechanism of metformin action.
    Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
    J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMP-activated protein kinase negatively regulates FcεRI-mediated mast cell signaling and anaphylaxis in mice.
    Hwang SL; Li X; Lu Y; Jin Y; Jeong YT; Kim YD; Lee IK; Taketomi Y; Sato H; Cho YS; Murakami M; Chang HW
    J Allergy Clin Immunol; 2013 Sep; 132(3):729-736.e12. PubMed ID: 23587332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
    Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
    Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.
    Kimura N; Tokunaga C; Dalal S; Richardson C; Yoshino K; Hara K; Kemp BE; Witters LA; Mimura O; Yonezawa K
    Genes Cells; 2003 Jan; 8(1):65-79. PubMed ID: 12558800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
    Krishan S; Richardson DR; Sahni S
    Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics.
    Arkwright RT; Deshmukh R; Adapa N; Stevens R; Zonder E; Zhang Z; Farshi P; Ahmed RS; El-Banna HA; Chan TH; Dou QP
    Anticancer Agents Med Chem; 2015; 15(5):657-71. PubMed ID: 25511514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Cellular Energy Metabolism Contributes to Duck-Enteritis-Virus-Induced Autophagy via the AMPK-TSC2-MTOR Signaling Pathway.
    Yin H; Zhao L; Li S; Xu L; Wang Y; Chen H
    Front Cell Infect Microbiol; 2017; 7():423. PubMed ID: 29018776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
    O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
    Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.